Setback For Dr. Reddy’s As U.S. FDA Hands Out Complete Response Letter For NuvaRing
Workers check automatic packaging of medicine tablets manufactured at Dr Reddy’s plant in Bachupally, Andra Pradesh state, India. (Photographer: Amit Bhargava/Bloomberg News)

Setback For Dr. Reddy’s As U.S. FDA Hands Out Complete Response Letter For NuvaRing

Shares of Dr. Reddy’s Laboratories Ltd. fell to their lowest in six months after the drugmaker’s plans to launch a generic version of a female contraceptive in the U.S. hit a roadblock.In a stateme...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.